(1)
Real-World Expenditures and Survival Time After CAR-T Treatment for Large B-Cell Lymphoma in Switzerland: A Retrospective Study Using Insurance Claims Data. Swiss Med Wkly 2023, 153 (9), s3441 . https://doi.org/10.57187/s.3441.